Sub-Division Of Shares: Mid Cap Pharma Stock Set To Go 1:2 Ex-Split Tomorrow

Mid cap company from the pharmaceuticals sector, J B Chemicals & Pharmaceuticals is all set to trade ex-split in the ratio of 1:2 on September 18, 2023. Last trading price of J B Chemicals share is Rs 2955.80 apiece with intraday fall of 0.61%. J B Chemicals shares offered return of 36% in last 3-months and 50% YTD. J B Chemicals stock soared 767% in last 5-years. Check details below:

J B Chemicals To Go Ex-Split Tomorrow: According to the BSE filing issued on August 29 the company fixed September 18, 2023 as the record date for stock split. The company said in the regulatory filing, "Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed September 18, 2023 as record date, to ascertain eligibility of the beneficial owners/shareholders of the Company for the purpose of Split/ SubDivision of 1 equity share of Rs. 2/- each into 2 equity shares of Re. 1/- each."

J B Chemicals Stock Performance And Return In Last Few Years: Last trading price of J B Chemicals stock is Rs 2955.80 per share on BSE. Its 52-week high price is Rs 3049.15 per share and 52-week low price is Rs 1817.05 per share, respectively. The company has a market capitalisation of Rs 22,896.81 crore. J B Chemicals shares witnessed a gain of 51% in last 1-year, soared 71% in last 2-years, and jumped 229% in last 3-years. In last 10-years, J B Chemicals shares rallied 3393%.

J B Chemicals Financials: The leading drug company announced a surge of 35% year-on-year (YoY) in net profit to Rs 142 crore for the first quarter ended June 30, 2023 as against Rs 105 crore announced in the corresponding quarter of last year. Meanwhile, it announced its total revenue at Rs 896 core during the period under consideration, up 14% as compared to Rs 785 crore in the corresponding period of last fiscal. The company's EBITDA, at the operating level, soared 28% to Rs 243 crore in the first quarter of this year as against Rs 190 crore in the corresponding period of last fiscal.

About: J B Chemicals & Pharmaceuticals Limited is a leading India-based pharmaceutical company. It is engaged in the business of manufacturing and marketing of vast range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance, among others.

Disclaimer: The stock just highlights the stock split and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for ay losses. Please consult a professional advisor.